A. Delacauw

Activation of deoxycytidine kinase by protein kinase inhibitors and okadaic acid in leukemic cells.

C. Smal, F. Bontemps, E. W. Van Den Neste, 2004, Biochemical pharmacology.

Metabolism and cytotoxic effects of 2-chloroadenine, the major catabolite of 2-chloro-2'-deoxyadenosine.

F. Bontemps, E. W. Van Den Neste, S. Cardoen, 2000, Biochemical pharmacology.

Activation of deoxycytidine kinase by UV-C-irradiation in chronic lymphocytic leukemia B-lymphocytes.

C. Smal, F. Bontemps, E. W. Van Den Neste, 2003, Biochemical pharmacology.

2-Chloro-2′-deoxyadenosine inhibits DNA repair synthesis and potentiates UVC cytotoxicity in chronic lymphocytic leukemia B lymphocytes

F. Bontemps, A. Ferrant, G. Berghe, 2002, Leukemia.

Resistance to 2-chloro-2'-deoxyadenosine of the human B-cell leukemia cell line EHEB.

C. Smal, F. Bontemps, A. Ferrant, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Potentiation of antitumor effects of cyclophosphamide derivatives in B-chronic lymphocytic leukemia cells by 2-chloro-2′-deoxyadenosine

V. Deneys, F. Bontemps, A. Ferrant, 1999, Leukemia.

Study of the Efficacy of a Pronucleotide of 2-Chloro-2′-Deoxyadenosine in Deoxycytidine Kinase-Deficient Lymphoma Cells

C. Galmarini, F. Bontemps, J. Balzarini, 2006, Nucleosides, nucleotides & nucleic acids.